Related Experiment Videos
Inhibition of prostate ductal morphogenesis by retinoic acid
1Department of Urology, Northwestern Medical School, Chicago, Illinois 60611-7275, USA.
Purpose:
To examine the effect of retinoic acid on prostate ductal morphogenesis.
Materials And Methods:
Newborn male Balb/C mice were injected with 25 mg./kg. all-trans retinoic acid or vehicle alone. Animals were sacrificed at 60 days of age and prostate ductal morphology was quantitatively assessed by microdissection. Total prostate DNA was quantitated by DPA assay.
Results:
The greatest effect was seen in the ventral prostate. Retinoic acid treated animals showed a 20% decrease in mean number of branch-points (p = 0.0006) with a corresponding 13% decrease in duct tips (p = 0.026). The combined ventral and dorsal prostate showed an effect with a 12% decrease in ductal branchpoints (p = 0.048). There was no effect on animal or organ weight and no effect on DNA content within the prostate. There was no difference in the prostate histology of treated and control animals.
Conclusion:
Retinoic acid administration in the newborn period inhibits mouse prostate ductal morphogenesis. This effect appears independent of an inhibition of overall growth.
Insights
Retinoic acid given to newborn mice significantly inhibited prostate ductal morphogenesis, reducing branch points and duct tips without affecting overall growth. This finding highlights retinoic acid
Area of Science:
- Developmental biology
- Urology
- Endocrinology
Background:
- Prostate ductal morphogenesis is a complex developmental process.
- Retinoids, including retinoic acid, are known regulators of cell differentiation and development.
- Understanding factors influencing prostate development is crucial for addressing congenital abnormalities and diseases.
Purpose of the Study:
- To investigate the impact of all-trans retinoic acid exposure during the neonatal period on mouse prostate ductal morphogenesis.
- To quantitatively assess changes in prostate ductal structure following retinoic acid administration.
Main Methods:
- Neonatal male Balb/C mice were administered all-trans retinoic acid (25 mg./kg.) or a vehicle control.
- Prostate ductal morphology was evaluated at 60 days of age using microdissection.
- DNA content was quantified using a DPA assay.
Main Results:
- All-trans retinoic acid treatment led to a significant reduction in ventral prostate branch points (20% decrease, p=0.0006) and duct tips (13% decrease, p=0.026).
- A combined analysis of ventral and dorsal prostate showed a 12% decrease in ductal branch points (p=0.048).
- No significant effects were observed on animal or organ weight, or prostate DNA content.
Conclusions:
- Neonatal administration of retinoic acid inhibits mouse prostate ductal morphogenesis.
- The observed inhibition of morphogenesis is independent of effects on overall prostate or animal growth.
- These findings suggest a specific role for retinoic acid in regulating prostate development.